An influenza virus vector candidate vaccine stably expressing SARS-CoV-2 receptor-binding domain produces high and long-lasting neutralizing antibodies in mice
Yongzhen Zhao, Lingcai Zhao, Yingfei Li, Qingzheng Liu, Lulu Deng, Yuanlu Lu, Xiaoting Zhang, Shengmin Li, Jinying Ge, Zhigao Bu, Jihui Ping
Topics & Concepts
VirologyVirusBiologyHemagglutinin (influenza)AntibodyCoronavirusInfluenza A virusNeutralizing antibodyVector (molecular biology)ImmunologyRecombinant DNACoronavirus disease 2019 (COVID-19)MedicineInfectious disease (medical specialty)GenePathologyDiseaseBiochemistryInfluenza Virus Research StudiesRespiratory viral infections researchSARS-CoV-2 and COVID-19 Research